Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Botulinum toxin injections greatly reduced pain in Parry-Romberg syndrome.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Denosumab treatment for osteoporosis can cause hair loss.

New drug shows promise for better hair growth in baldness treatment.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Rituximab improved her dermatomyositis better than usual treatments.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Omalizumab can cause temporary hair loss but still works well for chronic urticaria.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Bicalutamide added no extra benefit over minoxidil alone for female-pattern hair loss.

Semaglutide may help some skin disorders but can also cause skin issues.

Dupilumab helps children with alopecia areata regrow hair safely.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

The Shumin device with doxycycline is more effective for rosacea than red light therapy.